drugset / Trial / NCT01871857
7% Hypertonic Saline for Acute Bronchiolitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Research suggests that hypertonic saline may improve mucous flow in infants with acute bronchiolitis. Data suggest a trend favoring reduced length of hospital stay and improved pulmonary scores with increasing concentration of nebulized solution to 3% and 5% saline as compared to 0.9% saline mixed with epinephrine. To our knowledge, 7% hypertonic saline has not been previously investigated. OUr hypothesis was that 7% hypertonic saline would improve bronchiolitis severity scores and admission rate.
Timeline
- Start
- 2010-11
- Primary completion
- 2012-08
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hypertonic saline | Unknown | 3 ml | Inhaled |
| Comparator | sodium chloride | Unknown | 3 ml | Inhaled |
| Comparator | Epinephrine | Other / unclassified | 0.5 ml | Inhaled |